[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alector Inc (ALEC)

Alector Inc (ALEC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 233,153
  • Shares Outstanding, K 111,025
  • Annual Sales, $ 21,050 K
  • Annual Income, $ -142,930 K
  • EBIT $ -156 M
  • EBITDA $ -153 M
  • 60-Month Beta 0.64
  • Price/Sales 12.87
  • Price/Cash Flow N/A
  • Price/Book 8.69

Options Overview Details

View History
  • Implied Volatility 129.16% (+3.08%)
  • Historical Volatility 88.75%
  • IV Percentile 7%
  • IV Rank 3.59%
  • IV High 905.32% on 11/13/25
  • IV Low 100.26% on 07/02/25
  • Expected Move (DTE 5) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.03
  • Today's Volume 116
  • Volume Avg (30-Day) 93
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 4,697
  • Open Int (30-Day) 4,875
  • Expected Range 2.10 to 2.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.29
  • Number of Estimates 5
  • High Estimate $-0.21
  • Low Estimate $-0.38
  • Prior Year $-0.30
  • Growth Rate Est. (year over year) +3.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.09 +0.36%
on 05/08/26
2.74 -23.33%
on 04/20/26
-0.32 (-13.22%)
since 04/08/26
3-Month
1.84 +14.13%
on 02/13/26
2.74 -23.33%
on 04/20/26
+0.14 (+7.14%)
since 02/06/26
52-Week
1.01 +107.92%
on 05/15/25
3.40 -38.23%
on 10/16/25
+1.06 (+101.92%)
since 05/08/25

Most Recent Stories

More News
Alector: Q1 Earnings Snapshot

Alector: Q1 Earnings Snapshot

ALEC : 2.10 (-13.93%)
Alector Reports First Quarter 2026 Financial Results and Provides Business Update

Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and siRNA, with continued progress across AL037/AL137 (ABC-enabled antibody for...

ALEC : 2.10 (-13.93%)
Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis

--Independent data monitoring committee (IDMC) determined the trial unlikely to meet primary endpoint –  --Alector remains focused on advancing its pipeline of novel ABC-enabled candidates, including...

ALEC : 2.10 (-13.93%)
Alector: Q4 Earnings Snapshot

Alector: Q4 Earnings Snapshot

ALEC : 2.10 (-13.93%)
Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and siRNA, with continued progress across AL137 (ABC-enabled anti-amyloid antibody...

ALEC : 2.10 (-13.93%)
Alector to Participate in the TD Cowen 46th Annual Health Care Conference

SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression...

ALEC : 2.10 (-13.93%)
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer

SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression...

ALEC : 2.10 (-13.93%)
Alector to Participate in the Bank of America CNS Therapeutics Conference

SOUTH SAN FRANCISCO, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression...

ALEC : 2.10 (-13.93%)
ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alector, Inc. (“Alector” or “the Company”) (NASDAQ:...

ALEC : 2.10 (-13.93%)
Alector: Q3 Earnings Snapshot

Alector: Q3 Earnings Snapshot

ALEC : 2.10 (-13.93%)

Business Summary

Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco,...

See More

Key Turning Points

3rd Resistance Point 2.49
2nd Resistance Point 2.41
1st Resistance Point 2.26
Last Price 2.10
1st Support Level 2.02
2nd Support Level 1.94
3rd Support Level 1.78

See More

52-Week High 3.40
Fibonacci 61.8% 2.49
Fibonacci 50% 2.20
Last Price 2.10
Fibonacci 38.2% 1.92
52-Week Low 1.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.